Organogenesis Hldgs Q2 Sales $130.234M Beat $121.850M Estimate
Portfolio Pulse from Benzinga Newsdesk
Organogenesis Holdings (NASDAQ:ORGO) reported Q2 sales of $130.234 million, surpassing the analyst consensus estimate of $121.850 million by 6.88%. This represents an 11.01% increase from the same period last year.
August 08, 2024 | 9:48 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Organogenesis Holdings reported Q2 sales of $130.234 million, beating the analyst consensus estimate by 6.88% and showing an 11.01% year-over-year increase.
The company's better-than-expected sales performance and significant year-over-year growth are likely to positively impact its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100